ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31682-10mg |
|
1334850-99-5 |
Mito-TEMPO
|
0 | C29H35ClN2O2P | |
GC31682-5mg |
|
1334850-99-5 |
Mito-TEMPO
|
0 | C29H35ClN2O2P | |
GC31682-10mM (in 1mL DMSO) |
|
1334850-99-5 |
Mito-TEMPO
|
0 | C29H35ClN2O2P | |
GC31681-100mg |
|
65513-72-6 |
Glafenine hydrochloride (Glafenin hydrochloride)
|
0 | C19H18Cl2N2O4 | |
GC31681-10mM(1mLinDMSO) |
|
65513-72-6 |
Glafenine hydrochloride (Glafenin hydrochloride)
|
0 | C19H18Cl2N2O4 | |
GC31680-10mg |
|
1253186-49-0 |
GSK-5498A
|
0 | C18H11F6N3O | |
GC31680-5mg |
|
1253186-49-0 |
GSK-5498A
|
0 | C18H11F6N3O | |
GC31680-2mg |
|
1253186-49-0 |
GSK-5498A
|
0 | C18H11F6N3O | |
GC31680-10mM(1mLinDMSO) |
|
1253186-49-0 |
GSK-5498A
|
0 | C18H11F6N3O | |
GC31679-100mg |
|
2095393-15-8 |
ARQ 531
|
0 | C25H23ClN4O4 | |
GC31679-50mg |
|
2095393-15-8 |
ARQ 531
|
0 | C25H23ClN4O4 | |
GC31679-25mg |
|
2095393-15-8 |
ARQ 531
|
0 | C25H23ClN4O4 | |
GC31679-10mg |
|
2095393-15-8 |
ARQ 531
|
0 | C25H23ClN4O4 | |
GC31679-5mg |
|
2095393-15-8 |
ARQ 531
|
0 | C25H23ClN4O4 | |
GC31679-10mM(1mLinDMSO) |
|
2095393-15-8 |
ARQ 531
|
0 | C25H23ClN4O4 | |
GC31678-50mg |
|
148554-65-8 |
Seco Rapamycin sodium salt (Secorapamycin A monosodium)
|
0 | C51H78NNaO13 | |
GC31678-25mg |
|
148554-65-8 |
Seco Rapamycin sodium salt (Secorapamycin A monosodium)
|
0 | C51H78NNaO13 | |
GC31678-10mg |
|
148554-65-8 |
Seco Rapamycin sodium salt (Secorapamycin A monosodium)
|
0 | C51H78NNaO13 | |
GC31678-5mg |
|
148554-65-8 |
Seco Rapamycin sodium salt (Secorapamycin A monosodium)
|
0 | C51H78NNaO13 | |
GC31678-1mg |
|
148554-65-8 |
Seco Rapamycin sodium salt (Secorapamycin A monosodium)
|
0 | C51H78NNaO13 | |